Complete Filing Data
Hinge Health, Inc. reported Stockholders Equity of $178.66 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Hinge Health, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$88.0K | $8.0K | $135.0K |
| Net Income Loss | -$528.3M | -$11.9M | -$108.1M |
| Selling And Marketing Expense | $317.0M | $167.1M | $147.6M |
| Revenue From Contract With Customer Excluding Assessed Tax | $587.9M | $390.4M | $292.7M |
| Research And Development Expense | $368.1M | $100.8M | $110.1M |
| Operating Income Loss | -$546.4M | -$31.9M | -$130.5M |
| Operating Expenses | $1.01B | $331.8M | $324.7M |
| Nonoperating Income Expense | $19.1M | $20.7M | $22.0M |
| Net Income Loss Available To Common Stockholders Basic | -$424.1M | -$11.9M | -$108.1M |
| Income Tax Expense Benefit | $998.0K | $677.0K | -$405.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$527.3M | -$11.3M | -$108.5M |
| Gross Profit | $468.2M | $299.9M | $194.2M |
| General And Administrative Expense | $329.5M | $63.9M | $67.0M |
| Cost Of Revenue | $119.6M | $90.5M | $98.6M |
| Comprehensive Income Net Of Tax | -$528.3M | -$11.9M | -$108.0M |
| Income Taxes Paid Net | $1.6M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $87.0K | -$44.0K | -$58.0K | $261.0K | -$11.0K | -$105.0K |
| Net Income Loss | -$1.8M | -$575.7M | $17.1M | $341.0K | -$12.9M | -$26.5M |
| Selling And Marketing Expense | $63.5M | $147.2M | $44.6M | $44.9M | ||
| Revenue From Contract With Customer Excluding Assessed Tax | $154.2M | $139.1M | $100.6M | $89.8M | ||
| Research And Development Expense | $31.9M | $280.0M | $23.8M | $24.9M | ||
| Operating Income Loss | -$6.1M | -$580.7M | -$3.8M | -$17.6M | ||
| Operating Expenses | $132.3M | $678.4M | $83.1M | $84.2M | ||
| Nonoperating Income Expense | $4.5M | $4.7M | $5.3M | $5.0M | ||
| Net Income Loss Available To Common Stockholders Basic | -$1.8M | -$575.7M | $72.0K | -$12.9M | ||
| Income Tax Expense Benefit | $206.0K | -$326.0K | $1.1M | $361.0K | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$1.6M | -$576.0M | $1.5M | -$12.6M | ||
| Gross Profit | $126.2M | $97.8M | $79.3M | $66.6M | ||
| General And Administrative Expense | $36.9M | $251.2M | $14.7M | $14.4M | ||
| Cost Of Revenue | $28.0M | $41.3M | $21.4M | $23.2M | ||
| Comprehensive Income Net Of Tax | -$1.8M | -$575.7M | $602.0K | -$12.9M | ||
| Income Taxes Paid Net |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Stockholders Equity | $178.7M | -$434.6M | -$424.0M | -$318.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $209.8M | $302.6M | $237.5M | $302.9M |
| Temporary Equity Adjustment To Reflect Deemed Contribution From Redeemable Convertible Preferred Stock Extinguishment | $104.2M | $0.00 | $0.00 | |
| Inventory Write Down | $0.00 | $1.8M | $10.3M | |
| Cash And Cash Equivalents At Carrying Value | $208.0M | $300.8M | $235.0M | |
| Temporary Equity Carrying Amount Attributable To Parent | $199.9M | $851.3M | $851.3M | $851.3M |
| Deferred Commissions Current | $31.3M | $18.6M | ||
| Unpaid Deferred Offering Costs | $20.0K | $210.0K | $389.0K | |
| Restricted Cash And Cash Equivalents | $1.8M | $1.8M | $2.5M | |
| Provision For Loan Lease And Other Losses | $3.1M | $5.4M | $4.9M | |
| Operating Lease Expense | $3.4M | $3.6M | $3.3M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$92.8M | $65.1M | -$65.4M | |
| Amortization Of Deferred Sales Commissions | $46.7M | $29.9M | $20.3M | |
| Accretion Amortization Of Discounts And Premiums Investments | -$361.0K | -$537.0K | $10.8M | |
| Retained Earnings Accumulated Deficit | -$1.05B | -$522.7M | ||
| Property Plant And Equipment Net | $10.5M | $7.4M | ||
| Prepaid Expense And Other Assets Current | $57.0M | $44.9M | ||
| Other Assets Noncurrent | $13.7M | $9.4M | ||
| Operating Lease Right Of Use Asset | $6.9M | $9.6M | ||
| Operating Lease Liability Noncurrent | $3.8M | $7.3M | ||
| Operating Lease Liability Current | $4.2M | $3.8M | ||
| Liabilities Current | $362.4M | $249.3M | ||
| Liabilities And Stockholders Equity | $744.8M | $673.3M | ||
| Liabilities | $366.2M | $256.6M | ||
| Inventory Net | $15.6M | $10.9M | ||
| Intangible Assets Net Excluding Goodwill | $2.5M | $1.8M | ||
| Goodwill | $64.1M | $61.6M | ||
| Contract With Customer Liability Current | $300.9M | $217.6M | ||
| Assets Current | $533.9M | $583.4M | ||
| Assets | $744.8M | $673.3M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$20.0K | $68.0K | ||
| Accounts Receivable Net Current | $66.1M | $42.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Stockholders Equity | $208.0M | $173.8M | -$308.3M | -$461.8M | -$462.6M | -$450.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $263.1M | $239.0M | $269.7M | $238.8M | ||
| Temporary Equity Adjustment To Reflect Deemed Contribution From Redeemable Convertible Preferred Stock Extinguishment | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Inventory Write Down | $0.00 | $0.00 | $0.00 | $1.3M | ||
| Cash And Cash Equivalents At Carrying Value | $261.3M | $237.2M | $267.5M | $236.6M | ||
| Temporary Equity Carrying Amount Attributable To Parent | $199.9M | $199.9M | ||||
| Deferred Commissions Current | $29.1M | $24.4M | $17.2M | $16.0M | ||
| Unpaid Deferred Offering Costs | ||||||
| Restricted Cash And Cash Equivalents | $1.8M | $1.8M | $2.2M | $2.2M | ||
| Provision For Loan Lease And Other Losses | ||||||
| Operating Lease Expense | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | ||||||
| Amortization Of Deferred Sales Commissions | ||||||
| Accretion Amortization Of Discounts And Premiums Investments | ||||||
| Retained Earnings Accumulated Deficit | -$1.08B | -$1.08B | ||||
| Property Plant And Equipment Net | $8.4M | $7.7M | ||||
| Prepaid Expense And Other Assets Current | $49.2M | $47.5M | ||||
| Other Assets Noncurrent | $12.9M | $11.8M | ||||
| Operating Lease Right Of Use Asset | $7.7M | $8.6M | ||||
| Operating Lease Liability Noncurrent | $4.9M | $5.9M | ||||
| Operating Lease Liability Current | $4.2M | $4.0M | ||||
| Liabilities Current | $357.1M | $314.1M | ||||
| Liabilities And Stockholders Equity | $769.8M | $693.7M | ||||
| Liabilities | $361.9M | $320.0M | ||||
| Inventory Net | $13.8M | $14.0M | ||||
| Intangible Assets Net Excluding Goodwill | $2.7M | $3.0M | ||||
| Goodwill | $64.1M | $64.1M | ||||
| Contract With Customer Liability Current | $299.7M | $275.1M | ||||
| Assets Current | $658.9M | $598.4M | ||||
| Assets | $769.8M | $693.7M | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $53.0K | -$34.0K | ||||
| Accounts Receivable Net Current | $86.8M | $99.3M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Share Based Compensation | $643.0M | $739.0K | $1.6M |
| Proceeds From Stock Options Exercised | $1.4M | $610.0K | $492.0K |
| Proceeds From Sale And Maturity Of Marketable Securities | $368.6M | $346.6M | $459.5M |
| Payments To Acquire Property Plant And Equipment | $708.0K | $1.0M | $2.0M |
| Payments To Acquire Marketable Securities | $472.3M | $324.5M | $453.3M |
| Payments Of Stock Issuance Costs | $10.3M | $2.8M | $645.0K |
| Payments For Software | $5.4M | $2.7M | $2.6M |
| Net Cash Provided By Used In Operating Activities | $171.4M | $49.0M | -$63.9M |
| Net Cash Provided By Used In Investing Activities | -$113.8M | $18.3M | $1.5M |
| Net Cash Provided By Used In Financing Activities | -$150.5M | -$2.2M | -$3.0M |
| Increase Decrease In Prepaid Expenses Other | $15.8M | $9.2M | -$5.7M |
| Increase Decrease In Other Operating Assets | $181.0K | -$377.0K | -$677.0K |
| Increase Decrease In Operating Lease Liability | -$3.7M | -$4.7M | -$4.1M |
| Increase Decrease In Inventories | $4.8M | -$608.0K | -$10.6M |
| Increase Decrease In Deferred Compensation | -$63.6M | -$38.5M | -$27.8M |
| Increase Decrease In Contract With Customer Liability | $83.2M | $77.2M | $36.0M |
| Increase Decrease In Accounts Receivable | $26.6M | $1.3M | $23.1M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $29.4M | -$11.0M | $11.6M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 54.6M | 13.6M | 13.0M | |
| Weighted Average Number Of Diluted Shares Outstanding | 54.6M | 13.6M | 13.0M | |
| Earnings Per Share Diluted | $-7.77 | $-0.88 | $-8.31 | |
| Earnings Per Share Basic | $-7.77 | $-0.88 | $-8.31 | |
| Temporary Equity Shares Outstanding | 2.6M | 48.2M | 48.2M | 48.2M |
| Common Stock Shares Outstanding | 0.00 | 16.4M | ||
| Common Stock Shares Issued | 0.00 | 16.4M | ||
| Common Stock Shares Authorized | 0.00 | 98.1M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 78.9M | 43.9M | 13.6M | 13.5M |
| Weighted Average Number Of Diluted Shares Outstanding | 78.9M | 43.9M | 16.6M | 13.5M |
| Earnings Per Share Diluted | $-0.02 | $-13.10 | $0.01 | $-0.96 |
| Earnings Per Share Basic | $-0.02 | $-13.10 | $0.01 | $-0.96 |
| Temporary Equity Shares Outstanding | 2.6M | |||
| Common Stock Shares Outstanding | 0.00 | 0.00 | ||
| Common Stock Shares Issued | 0.00 | 0.00 | ||
| Common Stock Shares Authorized | 0.00 | 0.00 | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $1.4M | $610.0K | $492.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $644.3M | $739.0K | $1.6M |
| Other Noncash Income Expense | -$1.0K | -$7.0K | -$65.0K |
| Depreciation And Amortization | $5.1M | $6.0M | $5.6M |
| Additional Paid In Capital | $1.23B | $88.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $531.0K | $159.0K | $97.0K | $125.0K | $219.0K | $59.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $35.4M | $591.0M | $7.0K | $115.0K | $306.0K | $304.0K |
| Other Noncash Income Expense | ||||||
| Depreciation And Amortization | ||||||
| Additional Paid In Capital | $1.29B | $1.26B |
Most recent annual filing with the SEC: March 3, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.